Results 211 to 220 of about 228,751 (254)
Some of the next articles are maybe not open access.

Current Device Therapies for Sudden Cardiac Death Prevention – the ICD, Subcutaneous ICD and Wearable ICD

Heart Lung and Circulation, 2019
Defibrillator technology for sudden cardiac death (SCD) prevention now includes the transvenous implantable cardiac defibrillator (ICD), subcutaneous ICD (S-ICD) and wearable cardioverter defibrillator (WCD). ICD use improves survival in patients who survived previous sudden cardiac arrest (SCA) due to ventricular tachycardia (VT)/ventricular ...
David Chieng
exaly   +3 more sources

Inappropriate shocks in the subcutaneous ICD: Incidence, predictors and management

open access: yesInternational Journal of Cardiology, 2015
The entirely subcutaneous implantable cardioverter-defibrillator (S-ICD) eliminates the need for transvenous leads, and therefore has the potential to improve lead-longevity and reduce lead-related complications. The S-ICD has a morphology-based sensing algorithm of which inappropriate shocks have been reported.We analyzed the incidence, predictors and
Olde Nordkamp, Louise R A   +11 more
openaire   +4 more sources

Subcutaneous ICD sports safety registry (SISS registry)

open access: yesInternational Journal of Cardiology
Exercise has a positive impact on physical function and quality of life. However, individuals with an implantable cardioverter-defibrillator (ICD) may experience adverse events during sports activities. To date, scientific data on the safety of sports participation in patients with subcutaneous ICDs (S-ICDs) are lacking.
Nesti, Martina   +13 more
openaire   +3 more sources

Transvenous or Subcutaneous ICD — Similar but Different

New England Journal of Medicine, 2020
The results of the long-awaited Prospective Randomized Comparison of Subcutaneous and Transvenous Implantable Cardioverter Defibrillator Therapy (PRAETORIAN) trial — a randomized, controlled trial ...
Mark S, Link, Jose A, Joglar
openaire   +2 more sources

Recent developments in the subcutaneous ICD

Trends in Cardiovascular Medicine, 2016
The subcutaneous implantable cardioverter-defibrillator (ICD) was developed as a simple device to reduce the morbidity of ICD therapy while providing a comparable reduction in sudden death from ventricular fibrillation. This review highlights the differences compared to the traditional ICD.
Mark E, Willcox   +2 more
openaire   +2 more sources

A subcutaneous ICD—preliminary results

Nature Reviews Cardiology, 2010
N ...
Paolo Spirito, Giuseppe Boriani
openaire   +3 more sources

Implantation of a Fully Subcutaneous ICD in Children

Pacing and Clinical Electrophysiology, 2010
The subcutaneous implantable cardioverter defibrillator (S‐ICD) from Cameron Health (San Clemente, CA, USA) does not require a lead to be placed on or in the heart. Such a device, being subcutaneous, has potential benefits in children who require ICDs where problems largely relate to transvenous or epicardial leads and inappropriate shocks.
Karen A, McLeod, Andrew, McLean
openaire   +2 more sources

Use and outcomes of subcutaneous implantable cardioverter-defibrillator (ICD) after transvenous ICD extraction: An analysis of current clinical practice and a comparison with transvenous ICD reimplantation

open access: yesHeart Rhythm, 2019
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) does not require the insertion of any leads into the cardiovascular system. Objective: The aims of the study were to describe current practice and to measure outcomes associated ...
Federico Migliore
exaly   +2 more sources

Home - About - Disclaimer - Privacy